[Treatment of benign prostatic hyperplasia with antiandrogens (cyproterone acetate) and antiestrogens (tamoxifen)].
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004359:Drug Therapy, Combination; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013629:Tamoxifen / Q000627:therapeutic use*
D000726:Androgen Antagonists; D004965:Estrogen Antagonists; D013629:Tamoxifen; D017373:Cyproterone Acetate; D003534:Cyproterone
Trattamento dell'iperplasia prostatica benigna (IPB) con antiandrogeni (ciproterone acetato) e antiestrogeni (tamoxifene).